Alcohol Use Disorder Treatment Market Research and Forecast 2023 to 2033

Ganesh Shinde

Alcohol Use Disorder Treatment Market Research and Forecast 2023 to 2033

The global alcohol use disorder treatment market was worth US$ 700 million in 2023 and is expected to be worth US$ 1,300 million by 2033, growing at a CAGR of 6.4% between 2023 and 2033. The increased prevalence of alcohol abuse and binge drinking is expected to fuel the industry. This disease knows no bounds and can strike anyone, regardless of age or gender, resulting in a larger market for alcohol use disorder treatment.

Many nations have seen a rise in patient awareness, an increase in treatment-seeking frequency, increased government participation, and a greater emphasis on addiction reduction as a result of drug awareness campaigns and related preventative programs. Knowledge is disseminated via television advertising, newspapers, information booklets, and other forms of media, all of which benefit market expansion. The number of persons successfully treated for AUD is growing as a result of new medications that prevent deterioration while also regulating alcohol cravings.

More than 30,000 people die in the United States each year as a result of liver cirrhosis, the vast majority of which are the result of alcohol usage. Due to the availability of treatment medications and a well-developed health infrastructure, North America dominates the market for AUD treatment. Since, India and China are the most populous countries in the world; Asia Pacific has the highest population density. Owing to the increase in vulnerable adult population and strong demand for AUD treatment, the Asia-Pacific area is predicted to develop at a significant rate from 2023 to 2033.

Market Competition

Prominent players in the alcohol use disorder treatment market are Alkermes, Teva Pharmaceutical Industries Ltd., BioCorRx, Inc., Adial Pharmaceuticals, ADDEX THERAPEUTICS, Kinnov Therapeutics, Opiant Pharmaceuticals, Omeros Corporation, GlaxoSmithKline plc and Merck & Co. Inc.

Key Segments Profiled in the Alcohol Use Disorder Treatment Industry Survey

By Disorder Type:

Alcohol Abuse
Alcohol Dependence
Alcohol Addiction
Alcoholism

By Treatment Type:

Medication
Therapy
Multidisciplinary Treatment

Ganesh Shinde

Alcohol Use Disorder Treatment Market Analysis and Study 2023 to 2033

Ganesh Shinde 2023-03-20

The global alcohol use disorder treatment market globally was valued at US$ 700 million in 2023 and is projected to reach US$ 1,300 million by 2033, growing at a CAGR of 6. In the United States, more than 30,000 people die each year from liver cirrhosis, with the majority of cases resulting from alcohol use. North America dominates the market for AUD treatment due to the availability of treatment medications and a well-developed health infrastructure. The Asia-Pacific market is expected to grow significantly from 2023 to 2033 due to the increasing vulnerable adult population and strong demand for AUD treatment. com/reports/alcohol-use-disorder-treatment-marketKey Segments Profiled in the Alcohol Use Disorder Treatment Industry SurveyBy Disorder Type:Alcohol AbuseAlcohol DependenceAlcohol AddictionAlcoholismBy Treatment Type:MedicationTherapyMultidisciplinary Treatment

Alcohol Use Disorder Treatment Market 2023-2029 : COVID-19 Impact Analysis

ivy chen 2023-04-12

The global key players of Alcohol Use Disorder Treatment include Alkermes Plc. Companies, stakeholders, and other participants in the global Alcohol Use Disorder Treatment market will be able to gain the upper hand as they use the report as a powerful resource. com/reports/438157/alcohol-use-disorder-treatment-2029 Segment by Type Medication Therapy Multidisciplinary Treatment Segment by Application Hospital Clinic The report mentions the prominent market player consisting of: Alkermes Plc. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world. It is a leading global market research and consulting company.

Global Opioid Use Disorder Market Report 2021-2028 by Key Players Titan Pharmaceuticals, Hikma Pharmaceuticals, Teva Pharmaceuticals, MediciNova, Orexo, Camurus, Omeros

Sheryl Dias 2022-04-08

The global opioid use disorder market size is projected to expand at a significant CAGR during the forecast period, 2021–2028. About Growth Market Reports:GROWTH MARKET REPORTS provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Industry Intelligence Solutions”. Our key analysis segments, though not restricted to the same, include market entry strategies, market size estimations, market trend analysis, market opportunity analysis, market threat analysis, market growth/fall forecasting, primary interviews, secondary research & consumer surveys. Contact:Growth Market Reports Phone: +1 909 414 1393 Email: sales@growthmarketreports. com Follow Us: LinkedIn | Twitter

Opioid Use Disorder Market Competitive Strategies, Advertising Trends, Market Analysis by 2028

Data Bridge Market Research 2022-03-17

The Opioid Use Disorder Market is expected to witness market growth at a rate of 8. The Opioid Use Disorder Market Scope and SizeA credible Opioid Use Disorder Market research report is generated by using integrated approaches and latest technology for the best results. Global Opioid Use Disorder Market report is sure to help enhance sales and improve return on investment (ROI). , Alkermes, Novartis AG, Pear Therapeutics, Inc among other domestic and global playersMAJOR TOC OF THE REPORTChapter One: Opioid Use Disorder Market OverviewChapter Two: Manufacturers ProfilesChapter Three: Opioid Use Disorder Market Competition, by PlayersChapter Four: Opioid Use Disorder Market Size by RegionsChapter Five: Opioid Use Disorder Market Revenue by CountriesChapter Six: Opioid Use Disorder Market Revenue by TypeChapter Seven: Opioid Use Disorder Market Revenue by ApplicationChapter Eight: Opioid Use Disorder Market Revenue by IndustriesChapter Nine: Opioid Use Disorder Market Revenue by Deployment ModelChapter Ten: Opioid Use Disorder Market Revenue by End UserGet TOC Details: https://www. com

Growing Prevalence of Opioid Use Disorder Drives the Global Opioid Use Disorder Market

Ben Wood 2023-09-29

The global opioid use disorder market is estimated to be valued at US$2,739. The market for opioid use disorder treatments is witnessing significant growth due to the rising prevalence of opioid addiction worldwide. Overall, the global opioid use disorder market is witnessing significant growth due to the increasing prevalence of opioid Segment Analysis:The opioid use disorder market can be segmented by product type and end user. In terms of regional analysis, North America is expected to be the fastest-growing and dominating region in the opioid use disorder market. This can be attributed to the high prevalence of opioid use disorder in the region, favorable government initiatives to tackle the opioid crisis, and the presence of key market players.

Opioid Use Disorder Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Opioid Addiction

Anjali CMI 2023-09-29

The global Opioid Use Disorder Market is estimated to be valued at US$ 2,739. In conclusion, the Opioid Use Disorder Market is projected to witness high growth in the coming years, driven by the increasing prevalence of opioid addiction and the growing adoption of medication-assisted treatments. These trends highlight the need for effective interventions and support systems to address the challenges associated with opioid use disorder. Economic: The economic factors affecting the Opioid Use Disorder market include healthcare expenditure, insurance coverage, and affordability of opioid addiction treatments. In terms of regional analysis, North America is the fastest-growing and dominating region in the Opioid Use Disorder market.

WHO TO FOLLOW